Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation

Oncogene

Volumn 12, Issue 4, 1996, Pages 875-882

  Pocard, M ^a   Chevillard, S ^a   Villaudy, J ^a   Poupon, M F ^a   Dutrillaux, B ^a   Remvikos, Y ^a  

^a INSTITUT CURIE   (France)

Author keywords

Cell cycle arrest; Colon carcinoma; p53 mutations; Transfection

Indexed keywords

BROXURIDINE; COMPLEMENTARY DNA; MESSENGER RNA; MUTANT PROTEIN; PROTEIN P53;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER CELL CULTURE; CELL CLONE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COLON CARCINOMA; CONTROLLED STUDY; DNA INTEGRATION; DNA TRANSFECTION; EXPRESSION VECTOR; FLOW CYTOMETRY; IRRADIATION; MITOSIS INHIBITION; PLASMID; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION; SOUTHERN BLOTTING; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

ALANINE; BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME INHIBITORS; EXONS; G1 PHASE; GENE EXPRESSION; GENES, P53; HISTIDINE; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; S PHASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030044421     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Baker SJ, Markowitz S, Fearon ER, Wilson JK and Vogelstein B. (1990a). Science, 249, 912-915.
2. Baker SJ, Freisinger AC, Milburn Jessup J, Paraskeva C, Markowitz S, Wilson JKV, Hamilton S and Volgestein B. (1990b). Cancer Res., 50, 7717-7722.
3. Casey G, Lo-Hsueh M, Lopez ME, Volgestein B and Stanbridge EJ. (1991). Oncogene, 6, 1791-1797.
4. Chen P-L, Chen Y, Bookstein R and Lee W-H. (1990). Science, 250, 1576-1580.
5. Dean SW, Kincla L, Sykes HR, Lehman AR and Wise IA. (1989). Exp. Cell Res., 183, 473-783.
6. Deppert W. (1994). Sem. in Cancer Biol., 5, 187-202.
7. Donehower LA and Bradley A. (1993). Biochim. Biophys. Acta, 1155, 181-205.
8. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
9. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C. (1992). Nature, 358, 83-86.
10. Fearon ER and Vogelstein. (1990). Cell, 61, 759-767.
11. Finlay CA, Hinds PW and Levine AJ. ( 1989). Cell, 57, 1083-1093.
12. Hall PA, McKee PH, du Menage H, Dover R and Lane DP. (1993). Oncogene, 8, 203-207.
13. Hann and Lane (1995). Nature Genet., 9, 221-222.
14. Harper JW, Adami GR, Wei N, Keyomarki K and Elledge SJ. (1993). Cell, 75, 805-816.
15. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B and Levine AJ. (1990). Cell Growth Different., 1, 571-580.
16. Holstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.1.
17. Hupp TR, Meek DW, Midgely CA and Lane DP. (1993). Nuclei Acids Res., 21, 3167-3174.
18. Johnson P, Gray D, Mowat M, Benchimol S. (1991). Mol. Cell Biol., 11, 1-11.
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. (1991). Cancer Res., 51, 6304-6311.
20. Kern SE, Pietenol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. (1992). Science, 256, 827-830.
21. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
22. Lane DP. (1994). Int. J. Cancer, 57, 623-627.
23. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, Peltomaki P, De La Chapelle A, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Nature Genet., 9, 48-55.
24. Lu X, Perk SH, Thompson TC and Lane DP. (1992). Cell, 70, 153-161.
25. Lu X and Lane DP. (1993). Cell, 75, 765-778.
26. Mercer WE, Shields MT, Amin M, Sauve GJ, Apella E and Ullrich SJ. (1990). Proc. Natl. Acad. Sci. USA, 87, 6166-6170.
27. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D. (1994). Cancer Res., 54, 3391-3395.
28. Milner J and Medcalf EA. (1991). Cell, 65, 765-774.
29. Moll UM, Riou G and Levine AJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 7262-7266.
30. Muleris M, Salmon RJ and Dutrillaux B. (1988). Cancer Genet. Cytogenet., 32, 43-50.
31. Smith ML, Chen IT, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM and Fornace AJ. (1994). Science, 266, 1376-1380.
32. Tominaga O, Hamelin R, Trouvat V, Lesec G, Salmon RJ, Thomas G and Remvikos Y. (1993). Oncogene, 8, 2653-2658.
33. Tominaga O, Hamelin R, Remvikos Y, Salmon RJ and Thomas G. (1992). Critical Reviews in Oncogenesis, 3, 257-282.
34. Ullrich SJ, Mercer WE and Apella E. (1992). Oncogene, 7, 1635-1643.
35. Vogelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
36. Vsojtesek B and Lane DP. (1993). J. Cell Sciences, 105, 607-612.
37. Williams AC, Miller JC, Collard TJ, Bracey TS, Cosulich S and Paraskeva C. (1995). Oncogene, 11, 141-149.
38. Zhan G, Carrier F and Fornace AJ, Jr. (1993). Mol. Cell Biol., 13, 4242-4250.